Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Joshua Feuer, MD

Owner
Joshua M. Feuer, MD
Member of the Healthcare Council

Joshua Feuer, MD, FACC, is a board certified Cardiologist in private practice in Santa Barbara, California. He also serves as a Consulting Cardiologist at Santa Barbara Cottage Hospital. Dr. Feuer specializes in aggressive preventive cardiology and cardiovascular risk assessment, and reduction. He has expertise in diagnosis and treatment of cardiac arrhythmias, coronary artery disease, congestive heart failure, hypercholesterolemia, hypertension, and valvular heart disease. Dr. Feuer is a Fellow of American College of Cardiology and the Council of Clinical Cardiology of American Heart Association. He has published several articles on coronary artery disease, congestive heart failure, and pacemakers. (This is me - Update Profile)


Employment History
1998 - present Owner
Joshua M. Feuer, MD
1990 - 1998 Staff Physician in Department of Cardiology
Sansum Clinic
1988 - 1990 Staff Physician in Department of Cardiology
Long Beach VA Medical Center

GLG Study Groups with Joshua Feuer, MD(?)

View All Study Groups with Joshua Feuer, MD

GLG NewsSM Analyses by Joshua Feuer, MD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Niacin...it's deja vu all over again. | 01-29-2007
Analysis of: An Old Cholesterol Remedy Is New Again | www.nytimes.com
Author: Joshua Feuer, MD, Owner, Joshua M. Feuer, MD

1. Pfizer Inc, the pharmaceutical giant, halted late-stage trials of the HDL increasing drug torcetrapib after investigators discovered that it increased heart problems and increased death rates in the treated population. 2. Niacin, a B vitamin that increases HDL (the good cholesterol) up to 35%, has...

GLG InstituteSM Seminars with Joshua Feuer, MD(?)

 
Joshua Feuer, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Joshua Feuer, MD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics